In conclusion, we unravel an unrecognized LepR neuron Sh2b1/SNS/adipose energy expenditure axis that combats against obesity, type 2 diabetes, and NAFLD. Here, LEPR is linked to metabolic dysfunction-associated steatotic liver disease.